1)TrkB酪氨酸激酶受体B
1.The Expression of BDNF and TrkB in Rat Cerebellum;脑源性神经营养因子及酪氨酸激酶受体B在大鼠小脑的表达
2.Background and purpose:TrkB, a neurotrophic tyrosine kinase receptor,serves as a potent and specific suppressor of anoikis of non-malignant epithelial cells, and confers high metastatic capacity to these cells.背景与目的:失巢凋亡抑制因子酪氨酸激酶受体B(tyrosine kinase receptor, TrkB)能诱导正常上皮细胞的恶性转化并且使该细胞具有高转移能力。
3.Background and purpose:TrkB,a neurotrophic tyrosine kinase receptor,serves as a potent and specific suppressor of anoikis of non-malignant epithelial cells,and induces high invasion capacity in these cells.背景与目的:失巢凋亡抑制因子酪氨酸激酶受体B(tyrosine kinase receptor,TrkB)能诱导正常上皮细胞的恶性转化并且使该细胞具有高侵袭能力。
英文短句/例句
1.Experimental Studies on Rat Bone Marrow Stromal Cells Modified with Protein-tyrosine Kinase Receptor B Gene;蛋白酪氨酸激酶受体B基因修饰骨髓基质细胞的实验研究
2.Detection of TrkB and BDNF gene expression in nasopharyngeal carcinoma by real-time RT-PCR酪氨酸激酶受体B与脑源性神经营养因子mRNA在鼻咽癌中的定量表达
3.Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
4.c-Abl Stabilizes Estrogen Receptor by Phosphorylation and Regulates Its Transcription Activity;c-Abl非受体酪氨酸激酶调节ERα转录活性的研究
5.Expression and Clinical Significance of Receptor Tyrosine Kinase RON in Lung Carcinoma肺癌组织中酪氨酸激酶受体RON的表达及意义
6.Molecular targeted therapies:targeting receptor tyrosine kinases in the treatment of gastric cancer靶向于受体酪氨酸激酶的胃癌分子靶向治疗
7.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
8.Expression of receptor tyrosine kinase EphA7 in gastric carcinoma and its clinical significances受体酪氨酸激酶EphA7基因在胃癌中的表达及意义
9.Effect of Receptor Protein-tyrosine Kinases in Tumor Angiogenesis受体酪氨酸激酶在肿瘤血管新生中的作用
10.Progress in research of multi-targeted inhibitors of receptor tyrosine kinase多靶点受体酪氨酸激酶抑制剂的研究进展
11.Preparation of Monoclonal Antibodies Against RON Receptor Tyrosine Kinase;抗RON受体酪氨酸激酶单克隆抗体的制备和生物学特性研究
12.The inhibitor of VEGF receptor tyrosine kinase was introduced in detail.详细介绍了VEGF受体酪氨酸激酶抑制剂的研究进展。
13.The Effect of Receptor Tyrosine Kinase Inhibitor on Repair Tissue in Chondrocyte and Osteoarthritis Cartilage;受体酪氨酸激酶抑制剂在软骨修复中的作用研究
14.Prevalence and Clinical Significance of Type Ⅲ Receptor Tyrosine Kinases in Acute Leukemia;Ⅲ型受体酪氨酸激酶与急性白血病的关系及临床意义
15.The Study on the Transcripition Activity Modulation of C/EBPβ by c-Abl Non-Receptor Tyrosine Kinase;c-Abl非受体酪氨酸激酶调节C/EBPβ转录活性的研究
16.The Experimental Study on the Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor on Polycystic Kidney Disease;表皮生长因子受体酪氨酸激酶抑制剂治疗多囊肾病的实验研究
17.Expression and Mutational Analysis of Receptor of Tyrosine Kinase in Neuroendocrine Lung Carcinoma;酪氨酸激酶受体表达、突变与肺神经内分泌癌患者临床预后关系
18.A Study on the Prokaryotic and Eukaryotic Expression of Human EGFR Intracellular Tyrosine Kinase Domain;表皮生长因子受体胞内酪氨酸激酶结构域的原核及真核表达研究
相关短句/例句
Tyrosine kinase receptor B酪氨酸蛋白激酶受体B
1.Expression of tyrosine kinase receptor B in human follicle;酪氨酸蛋白激酶受体B在人卵泡中的表达及意义
2.BDNF initiate its biological effects by bounding to tyrosine kinase receptor B (TrkB) on the cell membrane.目的:关于人卵泡液中存在着由卵丘颗粒细胞分泌的脑源性神经营养因子(BDNF)的报道提示:人卵巢中可能有BDNF赖以发挥其生物学效应的特异性高亲合力受体—酪氨酸蛋白激酶受体B(TrkB)的存在。
3)TrkB酪氨酸激酶B受体
1.Study on the Expression of BDNF and TrkB in Rat Hippocampal Formation CA1;脑源性神经营养因子及酪氨酸激酶B受体在大鼠海马结构CA_1区的表达研究
4)Protein-tyrosine kinase receptor B蛋白酪氨酸激酶受体B
5)TrkB酪氨酸受体激酶B
1.Effect of Electroacupuncture of Different Acupoints on the Excitability of Detrusor Muscle and the Expression of BDNF and TrkB in the Spinal Cord of Rats with Urinary Retention due to Spinal Cord Injury电针不同穴位对脊髓损伤后尿潴留大鼠脊髓中脑源性神经营养因子及其酪氨酸受体激酶B表达的影响
6)Receptor tyrosine kinase受体酪氨酸激酶
1.Expression and its clinical significance of receptor tyrosine kinase EphB1 in gastric carcinoma受体酪氨酸激酶EphB1在胃癌中的表达及其临床意义
2.Mer is one member of Axl receptor tyrosine kinase family, and its ligand Gas6 can stimulate activity of Mer receptor tyrosine kinase after binding it, and then activate the downstream signal transduction pathway, Mer participates in cell inflammation, apoptosis, tumorigenesis, thrombosis and hemostasis.Mer是Axl受体酪氨酸激酶家族中的一员,其受体Gas6和Mer结合后可以激活Mer的酪氨酸激酶活性,并激活下游信号传导途径,在细胞炎症、凋亡、血液肿瘤发生发展以及血栓于止血等方面发挥作用。
3.FLT3,a member of receptor tyrosine kinase III family,is primarily expressed by hematopoietic cells and plays a significant role in hematopoiesis and leukemogenesis.FMS-like Tyrosine Kinase 3(FLT3)是一种受体酪氨酸激酶,在造血干细胞、前体B细胞等的增殖、分化以及存活中具有重要作用。
延伸阅读
酪氨酸蛋白激酶抑制剂分子式:CAS号:性质:一类能抑制蛋白质酪氨酸激酶活性的化合物。酪氨酸蛋白激酶能特异性地将磷酸根转移到蛋白质的酪氨酸残基上使其磷酸化,是许多配体活化的生长因子受体和一些癌基因产物,在肿瘤组织中含量高。酪氨酸蛋白激酶抑制剂可作为ATP与酪氨酸蛋白激酶结合的竞争性抑制剂,也可作为酪氨酸的类似物阻断表皮生长因子受体的肽位点和酪氨酸蛋白激酶的编码,抑制细胞增殖,可望开发为抗肿瘤药物,但对完整细胞没有表现出选择性。